---
document_datetime: 2025-05-23 08:53:01
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/revestive-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: revestive-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.4191734
conversion_datetime: 2025-12-26 20:57:24.825783
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Revestive

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproductlifecycleprocedures,please alsorefertoEPAR-Proceduralstepstakenandscientific informationafterauthorisation(archive).

| Applicationnumber   | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Article 61(3) /     | -Notification acc. Article 61(3) - | 22/05/2025                          |                                          | PL                              |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000272450                      | Update of the package leaflet with the additionofcontactdetailsoflocal representatives. In addition, the marketing authorisationholderhas takenthe opportunity to implement minor editorial changesinAnnexesIIAandIIIBof the Product Information for CS, IT, DE, DA, and PT.   |            |     |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000264402 | B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor changeinthemanufacturingprocess of the active substance-Accepted                                                                                                                        | 15/05/2025 | N/A |